Onemednet CORP 8-K filings

OneMedNet Corporation announced its 2026 Annual Meeting of Stockholders will be held on September 18, 2026, with a record date of August 11, 2026, and updated deadlines for shareholder proposals and director nominations.

OneMedNet Corporation has entered into a standby equity purchase agreement with YA II PN, Ltd. allowing for up to $25 million in potential capital raises over 36 months.

OneMedNet Corporation has been notified by Nasdaq of non-compliance with the minimum $1.00 bid price requirement.

OneMedNet Corporation's 2025 Annual Meeting saw stockholders elect two Class II Directors and ratify Withum Smith+Brown, PC as its independent auditor, alongside a Compensation Committee appointment.

Jair Clarke, a director at OneMedNet Corporation, will not stand for re-election at the company's 2025 Annual Meeting of Stockholders.

OneMedNet Corporation announced it has regained compliance with Nasdaq's minimum bid price requirement, resolving a previous listing issue.

OneMedNet Corporation announced it has regained compliance with Nasdaq's minimum market value requirement, resolving a previous listing deficiency.

OneMedNet Corporation announced the posting of a revised investor presentation to its website, providing updated information for stakeholders.

OneMedNet Corporation filed a Form 8-K to disclose the posting of an investor presentation on its investor relations website.

OneMedNet Corporation announced a series of strategic financial transactions, including a $3.7 million private placement and the conversion of approximately $6.5 million in outstanding loans and notes into equity, leading to a 60% reduction in total liabilities.

OneMedNet Corporation received a notice from Nasdaq indicating non-compliance with the minimum bid price requirement, potentially leading to delisting.

OneMedNet Corporation received a notification from Nasdaq regarding non-compliance with minimum market value, stockholders' equity, and net income requirements for continued listing.

OneMedNet Corporation announces the expansion of its Board of Directors and the appointment of Dr. Kenneth Alleyne as a new independent director, effective February 25, 2025.

OneMedNet Corporation announces the permanent appointment of Robert Golden as Chief Financial Officer, effective January 31, 2025.

OneMedNet Corporation has regained compliance with Nasdaq listing rules after filing its overdue quarterly reports for the first three quarters of 2024.

OneMedNet Corporation held its 2024 Annual Meeting of Stockholders, electing three Class I directors and ratifying the appointment of its independent accounting firm.

OneMedNet Corporation received a notice from Nasdaq for failing to file its quarterly report on time, putting its listing status at risk.

OneMedNet Corporation filed an amendment to its original 8-K report to include the consolidated financial statements of Legacy OneMedNet for the three and nine months ended September 30, 2023, and related management analysis.

OneMedNet Corporation's Audit Committee determined that previously issued financial statements for the year ended December 31, 2023, should no longer be relied upon due to accounting errors, necessitating a restatement.

OneMedNet Corporation has been notified by Nasdaq that its common stock has failed to meet the minimum bid price requirement for continued listing.

OneMedNet Corporation has received a notification from Nasdaq regarding its failure to meet minimum market value and financial requirements for continued listing.

OneMedNet Corporation announces changes to its Board of Directors, including the departure of two members and the appointment of two new independent directors, to enhance corporate governance and drive growth.

OneMedNet Corporation has successfully completed a follow-on private placement, raising approximately $1.7 million, and intends to use a portion of the proceeds to purchase Bitcoin.

OneMedNet Corporation received notices from Nasdaq for failing to file its quarterly reports on time, putting its listing status at risk.

OneMedNet Corporation has appointed Robert Golden as interim Chief Financial Officer, effective August 30, 2024, following the resignation of Lisa Embree.

OneMedNet Corporation's common stock and warrants will transfer from the Nasdaq Global Market to the Nasdaq Capital Market effective August 19, 2024.

OneMedNet Corporation reports the resignation of a board member and the appointment of a new director, effective August 12 and August 14, 2024, respectively.

OneMedNet Corporation has successfully completed a $4.6 million private placement with institutional investors, allocating a portion of the proceeds to Bitcoin.

OneMedNet Corporation is addressing a delay in filing its quarterly report, a change in auditors, and has secured a new financing agreement while regaining compliance with a Nasdaq listing rule.

OneMedNet Corporation terminated its previous funding agreement with Helena Global and entered into a new standby equity purchase agreement with YA II PN, Ltd. for up to $25 million.